Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
After Market: Stocks Finish Wild Week with a Whimper
View this photo on glassdoor.com
Breo Ellipta Sales Below Estimates, Says Leerink Swann (THRX) (GSK)
Correction to GSK Drug Studies Story
GlaxoSmithKline Studies on Lung Disease Drug Show Positive Results -- Update
Theravance, GSK announce positive results from combination therapy COPD study
GLAXOSMITHKLINE - Novel Combo Therapy (BRAF+MEK) Filed in Europe - Potential New SoC for BRAF Positive Metastatic Melanoma Patients
GlaxoSmithKline Mxico SA de CV in Consumer Health (Mexico) - new company profile report published
Are We Ignoring The Counter View On Five Prime?
GlaxoSmithKline Touts Positive Asthma Drug Results From Two Phase 3 Studies
Veeva: Irrefutable Proof Of TAM Overstatements, CRM Seat Saturation, Drastic Growth Deceleration, And Highly Dubious Sell-Side Coverage
GSK Takes the Step towards Total Transparency